Patient Reporting in the EU: Analysis of EudraVigilance Data
Sign Up to like & getrecommendations! Published in 2017 at "Drug Safety"
DOI: 10.1007/s40264-017-0534-1
Abstract: IntroductionNew pharmacovigilance legislation was adopted in the EU in 2010 and became operational in July 2012. The legislation placed an obligation on all national competent authorities (NCAs) and marketing authorisation holders (MAHs) to record and… read more here.
Keywords: eudravigilance; legislation; patient reports; patient reporting ... See more keywords
Identifying and managing ADRs: Qualitative analysis of patient reports to the UK Yellow Card Scheme.
Sign Up to like & getrecommendations! Published in 2022 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15263
Abstract: INTRODUCTION Adverse drug reactions (ADRs) can have significant negative impact on peoples' daily lives, with physical, economic, social and/or psychological effects. Patient reporting of ADRs has been facilitated by pharmacovigilance systems across Europe. However, capturing… read more here.
Keywords: patient reports; yellow card; free text; reports yellow ... See more keywords
Provision of Buprenorphine to Pregnant Women by For-Profit Clinics in an Appalachian City
Sign Up to like & getrecommendations! Published in 2018 at "Southern Medical Journal"
DOI: 10.14423/smj.0000000000000875
Abstract: Objectives This study was undertaken to confirm that patient reports on buprenorphine medication-assisted therapy in for-profit buprenorphine clinics in our community were personally costly. We contacted all 17 for-profit clinics in our community and confirmed… read more here.
Keywords: profit; city; patient reports; pregnant women ... See more keywords